| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2009-04-06 16:19:41 UTC |
|---|
| Update Date | 2023-02-21 17:17:38 UTC |
|---|
| HMDB ID | HMDB0012128 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | (R)-Amphetamine |
|---|
| Description | (R)-amphetamine is an enantiomer of amphetamine that is urinary metabolite from selegeline (drug used for the treatment of early-stage Parkinson's disease, depression and senile dementia). (R)-amphetamine as stereoisomer is not considered psychoactive and has little abuse potential. The stimulatory effect on locomotor activity and dopamine synthesis may be contributed to by the action of R-methamphetamine. If anyone is prescribed and takes selegiline, they can and will test positive for amphetamine/methamphetamine on most drug tests. |
|---|
| Structure | InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (-)-Amphetamine | ChEBI | | (-)-Phenylisopropylamine | ChEBI | | (R)-alpha-Methylbenzeneethanamine | ChEBI | | (R)-alpha-Methylphenethylamine | ChEBI | | Levamfetamine | ChEBI | | Levamphetamine | ChEBI | | (R)-a-Methylbenzeneethanamine | Generator | | (R)-Α-methylbenzeneethanamine | Generator | | (R)-a-Methylphenethylamine | Generator | | (R)-Α-methylphenethylamine | Generator | | Amfetamine | MeSH | | Amphetamine | MeSH | | Amphetamine sulfate | MeSH | | Amphetamine sulfate (2:1) | MeSH | | Centramina | MeSH | | Desoxynorephedrin | MeSH | | Fenamine | MeSH | | Levoamphetamine | MeSH | | Mydrial | MeSH | | Phenamine | MeSH | | Phenopromin | MeSH | | Sulfate, amphetamine | MeSH | | Thyramine | MeSH | | L Amphetamine | MeSH | | Levo amphetamine | MeSH | | Levo-amphetamine | MeSH | | (R)-a-Methyl-benzeneethanamine | HMDB | | (R)-alpha-Methyl-benzeneethanamine | HMDB | | (R)-Phenaminum | HMDB | | (R)-Phenylisopropylamine | HMDB | | L-(R)-Amphetamine | HMDB | | L-a-Methylphenethylamine | HMDB | | L-alpha-Methylphenethylamine | HMDB | | L-Amphetamine | HMDB | | Miquel brand OF amfetamine sulfate | MeSH, HMDB |
|
|---|
| Chemical Formula | C9H13N |
|---|
| Average Molecular Weight | 135.2062 |
|---|
| Monoisotopic Molecular Weight | 135.104799421 |
|---|
| IUPAC Name | (2R)-1-phenylpropan-2-amine |
|---|
| Traditional Name | (-)-amphetamine |
|---|
| CAS Registry Number | 156-34-3 |
|---|
| SMILES | C[C@@H](N)CC1=CC=CC=C1 |
|---|
| InChI Identifier | InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m1/s1 |
|---|
| InChI Key | KWTSXDURSIMDCE-MRVPVSSYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as amphetamines and derivatives. These are organic compounds containing or derived from 1-phenylpropan-2-amine. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Benzene and substituted derivatives |
|---|
| Sub Class | Phenethylamines |
|---|
| Direct Parent | Amphetamines and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Amphetamine or derivatives
- Phenylpropane
- Aralkylamine
- Organic nitrogen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Primary amine
- Organonitrogen compound
- Primary aliphatic amine
- Amine
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 2.74 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.3939 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 4.71 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 72.4 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1049.4 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 346.2 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 124.5 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 200.3 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 93.8 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 309.9 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 346.7 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 177.2 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 869.8 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 313.8 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 816.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 218.4 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 276.6 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 361.4 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 326.8 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 39.2 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| (R)-Amphetamine,1TMS,isomer #1 | C[C@H](CC1=CC=CC=C1)N[Si](C)(C)C | 1334.7 | Semi standard non polar | 33892256 | | (R)-Amphetamine,1TMS,isomer #1 | C[C@H](CC1=CC=CC=C1)N[Si](C)(C)C | 1339.0 | Standard non polar | 33892256 | | (R)-Amphetamine,1TMS,isomer #1 | C[C@H](CC1=CC=CC=C1)N[Si](C)(C)C | 1618.3 | Standard polar | 33892256 | | (R)-Amphetamine,2TMS,isomer #1 | C[C@H](CC1=CC=CC=C1)N([Si](C)(C)C)[Si](C)(C)C | 1539.5 | Semi standard non polar | 33892256 | | (R)-Amphetamine,2TMS,isomer #1 | C[C@H](CC1=CC=CC=C1)N([Si](C)(C)C)[Si](C)(C)C | 1524.0 | Standard non polar | 33892256 | | (R)-Amphetamine,2TMS,isomer #1 | C[C@H](CC1=CC=CC=C1)N([Si](C)(C)C)[Si](C)(C)C | 1644.4 | Standard polar | 33892256 | | (R)-Amphetamine,1TBDMS,isomer #1 | C[C@H](CC1=CC=CC=C1)N[Si](C)(C)C(C)(C)C | 1564.4 | Semi standard non polar | 33892256 | | (R)-Amphetamine,1TBDMS,isomer #1 | C[C@H](CC1=CC=CC=C1)N[Si](C)(C)C(C)(C)C | 1562.5 | Standard non polar | 33892256 | | (R)-Amphetamine,1TBDMS,isomer #1 | C[C@H](CC1=CC=CC=C1)N[Si](C)(C)C(C)(C)C | 1758.8 | Standard polar | 33892256 | | (R)-Amphetamine,2TBDMS,isomer #1 | C[C@H](CC1=CC=CC=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1970.2 | Semi standard non polar | 33892256 | | (R)-Amphetamine,2TBDMS,isomer #1 | C[C@H](CC1=CC=CC=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1936.9 | Standard non polar | 33892256 | | (R)-Amphetamine,2TBDMS,isomer #1 | C[C@H](CC1=CC=CC=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1881.7 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - (R)-Amphetamine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-9100000000-41224b447ebed58b4d86 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - (R)-Amphetamine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (R)-Amphetamine 10V, Positive-QTOF | splash10-00kr-0900000000-b3a524d7c495f48a74c3 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (R)-Amphetamine 20V, Positive-QTOF | splash10-014r-1900000000-081ce3a25bbacda4ab98 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (R)-Amphetamine 40V, Positive-QTOF | splash10-0006-9300000000-5195de4351c8a02eb232 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (R)-Amphetamine 10V, Negative-QTOF | splash10-001i-0900000000-22cd79bae5466b52ae0a | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (R)-Amphetamine 20V, Negative-QTOF | splash10-001i-1900000000-a4e4f7fb040e60f9e5ba | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (R)-Amphetamine 40V, Negative-QTOF | splash10-014l-4900000000-e652b091af97ea288b4c | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (R)-Amphetamine 10V, Positive-QTOF | splash10-00kf-6900000000-4f5d22828acdcb13d83e | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (R)-Amphetamine 20V, Positive-QTOF | splash10-0006-9000000000-c5766ace6b2031302336 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (R)-Amphetamine 40V, Positive-QTOF | splash10-0006-9000000000-c8535cbb285cac999590 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (R)-Amphetamine 10V, Negative-QTOF | splash10-0006-9200000000-0f66be3239e5e65d6028 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (R)-Amphetamine 20V, Negative-QTOF | splash10-0006-9100000000-6720c563d36a88e31cd6 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (R)-Amphetamine 40V, Negative-QTOF | splash10-002f-9000000000-f91f5b5177c2d32668fd | 2021-09-25 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
IR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted IR Spectrum | IR Ion Spectrum (Quadrupole Ion Trap, ESI+, Adduct: [M+H]+) | 2022-02-11 | FELIX lab | View Spectrum | | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
|---|